HIV-prevention drug to cost  a year from 2027

HIV-prevention drug to cost $40 a year from 2027

GENEVA: Generic versions of a groundbreaking injectable HIV-prevention drug will be available for $40 a year in over 100 countries starting in 2027, Unitaid and the Gates Foundation announced Wednesday. The two organizations have signed separate agreements with Indian pharmaceutical companies to produce cheaper generics of lenacapavir – a twice-yearly injection shown to reduce the…

Read More